# 5149
Reports of NDM-1 (New Delhi metallo-beta-lactamase-1), MRSA, Klebsiella pneumoniae carbapenemases (KPCs), along with other emerging resistant strains of bacteria, have received a lot of media attention of late – and deservedly so.
As Maryn McKenna so aptly described in her book SUPERBUG: The Fatal Menace of MRSA, we are facing a future with the grim prospect of having a dwindling arsenal of effective antibiotics.
Today, the NEJM has a long, and informative Perspective on the global threat of NDM-1 - and other resistant bacteria - by Robert C. Moellering, Jr., M.D., a Professor of Medical Research at Harvard Medical School.
It’s well worth checking out.
Perspective
NDM-1 — A Cause for Worldwide Concern
Robert C. Moellering, Jr., M.D.
N Engl J Med 2010; 363:2377-2379 December 16, 2010
